Curcumin Alleviates Matrix Metalloproteinase-3 and -9 Activities during Eradication of Helicobacter pylori Infection in Cultured Cells and Mice

Current therapy-regimens against Helicobacter pylori (Hp) infections have considerable failure rates and adverse side effects that urge the quest for an effective alternative therapy. We have shown that curcumin is capable of eradicating Hp-infection in mice. Here we examine the mechanism by which curcumin protects Hp infection in cultured cells and mice. Since, MMP-3 and -9 are inflammatory molecules associated to the pathogenesis of Hp-infection, we investigated the role of curcumin on inflammatory MMPs as well as proinflammatory molecules. Curcumin dose dependently suppressed MMP-3 and -9 expression in Hp infected human gastric epithelial (AGS) cells. Consistently, Hp-eradication by curcumin-therapy involved significant downregulation of MMP-3 and -9 activities and expression in both cytotoxic associated gene (cag)+ve and cag -ve Hp-infected mouse gastric tissues. Moreover, we demonstrate that the conventional triple therapy (TT) alleviated MMP-3 and -9 activities less efficiently than curcumin and curcumin's action on MMPs was linked to decreased pro-inflammatory molecules and activator protein-1 activation in Hp-infected gastric tissues. Although both curcumin and TT were associated with MMP-3 and -9 downregulation during Hp-eradication, but unlike TT, curcumin enhanced peroxisome proliferator-activated receptor-γ and inhibitor of kappa B-α. These data indicate that curcumin-mediated healing of Hp-infection involves regulation of MMP-3 and -9 activities.

[1]  R. Reiter,et al.  Melatonin promotes angiogenesis during protection and healing of indomethacin‐induced gastric ulcer: role of matrix metaloproteinase‐2 , 2010, Journal of pineal research.

[2]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[3]  A. Mobasheri,et al.  Targeting matrix metalloproteinases in inflammatory conditions. , 2009, Current drug targets.

[4]  G. Nair,et al.  Antimicrobial Activity of Curcumin against Helicobacter pylori Isolates from India and during Infections in Mice , 2009, Antimicrobial Agents and Chemotherapy.

[5]  D. Karunagaran,et al.  Anti-inflammatory effect of curcumin involves downregulation of MMP-9 in blood mononuclear cells. , 2007, International immunopharmacology.

[6]  Michael P Vitek,et al.  Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways , 2007, Proceedings of the National Academy of Sciences.

[7]  B. Aggarwal,et al.  Role of curcumin in cancer therapy. , 2007, Current problems in cancer.

[8]  A. Mobasheri,et al.  Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. , 2007, Biochemical pharmacology.

[9]  Takeshi Azuma,et al.  Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium , 2007, Nature Medicine.

[10]  D. Berg,et al.  Cag Pathogenicity Island-independent Up-regulation of Matrix Metalloproteinases-9 and -2 Secretion and Expression in Mice by Helicobacter pylori Infection* , 2006, Journal of Biological Chemistry.

[11]  Kunqian Yu,et al.  Biochemical characterization and inhibitor discovery of shikimate dehydrogenase from Helicobacter pylori , 2006, The FEBS journal.

[12]  R. Reiter,et al.  Hydrogen peroxide-mediated downregulation of matrix metalloprotease-2 in indomethacin-induced acute gastric ulceration is blocked by melatonin and other antioxidants. , 2006, Free radical biology & medicine.

[13]  Chang-sheng Deng,et al.  Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. , 2006, International immunopharmacology.

[14]  Christopher M. Overall,et al.  Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.

[15]  Hee-Sun Kim,et al.  Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. , 2005, Biochemical and biophysical research communications.

[16]  S. Fulda,et al.  Betulinic acid as new activator of NF-κB: molecular mechanisms and implications for cancer therapy , 2005, Oncogene.

[17]  Jaw-Town Lin,et al.  Helicobacter pylori promote gastric cancer cells invasion through a NF-kB and COX-2-mediated pathway , 2005 .

[18]  M. Blaser,et al.  Matrix Metalloproteinase Secretion by Gastric Epithelial Cells Is Regulated by E Prostaglandins and MAPKs* , 2005, Journal of Biological Chemistry.

[19]  P. Maity,et al.  Curcumin Regulates Expression and Activity of Matrix Metalloproteinases 9 and 2 during Prevention and Healing of Indomethacin-induced Gastric Ulcer* , 2005, Journal of Biological Chemistry.

[20]  P. Kim,et al.  Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-γ , 2004, Experimental & Molecular Medicine.

[21]  John Bertin,et al.  Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island , 2004, Nature Immunology.

[22]  K. Hahm,et al.  Decreased Helicobacter pylori associated gastric carcinogenesis in mice lacking inducible nitric oxide synthase , 2004, Gut.

[23]  Pascal Richette,et al.  Peroxisome Proliferator-activated Receptor-γ Down-regulates Chondrocyte Matrix Metalloproteinase-1 via a Novel Composite Element* , 2004, Journal of Biological Chemistry.

[24]  S. Williams,et al.  Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001. , 2004, Journal of medical microbiology.

[25]  P. Bergin,et al.  Increased Production of Matrix Metalloproteinases in Helicobacter pylori‐Associated Human Gastritis , 2004, Helicobacter.

[26]  M. Naumann,et al.  Curcumin blocks NF-kappaB and the motogenic response in Helicobacter pylori-infected epithelial cells. , 2004, Biochemical and biophysical research communications.

[27]  H. Goto Helicobacter pylori and gastric diseases. , 2003, Nagoya journal of medical science.

[28]  A. Smolka,et al.  Interleukin 1β induces gastric epithelial cell matrix metalloproteinase secretion and activation during Helicobacter pylori infection , 2003 .

[29]  C. Dinney,et al.  Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  E. Hahn,et al.  H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPAR gamma and impaired apoptosis in gastric carcinogenesis. , 2003, Medical science monitor : international medical journal of experimental and clinical research.

[31]  F. Campbell,et al.  Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration , 2003, Journal of Cell Science.

[32]  S. Falkow,et al.  Disruption of the Epithelial Apical-Junctional Complex by Helicobacter pylori CagA , 2003, Science.

[33]  T. Hirayama,et al.  Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor kappaB. , 2003, Gastroenterology.

[34]  G. Mahady,et al.  Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. , 2002, Anticancer research.

[35]  E. Masini,et al.  Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck , 2002, Cancer.

[36]  D. Berg,et al.  Virulence Genes in Helicobacter pylori Strains from West Bengal Residents with Overt H. pylori-Associated Disease and Healthy Volunteers , 2002, Journal of Clinical Microbiology.

[37]  Y. Surh,et al.  Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. , 2001, Mutation research.

[38]  J. Pelletier,et al.  Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. , 2001, Arthritis and rheumatism.

[39]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[40]  C. Overall,et al.  Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. , 2000, Science.

[41]  H. Pahl,et al.  Helicobacter pylori Activates Mitogen-activated Protein Kinase Cascades and Induces Expression of the Proto-oncogenes c-fos and c-jun * , 2000, The Journal of Biological Chemistry.

[42]  A. Terano,et al.  Chemokine expression in Helicobacter pylori-infected gastric mucosa , 1998, Journal of Gastroenterology.

[43]  C. O'Morain,et al.  Treatment of Helicobacter pylori , 2005, Helicobacter.

[44]  Christopher K. Glass,et al.  The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.

[45]  H. Pahl,et al.  A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B. , 1997, Journal of immunology.

[46]  M. Upton,et al.  Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. , 1997, Gastroenterology.

[47]  Mark Borodovsky,et al.  The complete genome sequence of the gastric pathogen Helicobacter pylori , 1997, Nature.

[48]  H. Vainio,et al.  Working group report on schistosomes, liver flukes and Helicobacter pylori. Meeting held at IARC, LYON, 7–14 june 1994 , 1995, International journal of cancer.

[49]  C. Kositchaiwat,et al.  Curcuma longa Linn. in the treatment of gastric ulcer comparison to liquid antacid: a controlled clinical trial. , 1993, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[50]  A. Shah,et al.  Toxicity studies on Alpinia galanga and Curcuma longa. , 1992, Planta medica.

[51]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[52]  C. H. Thienes FUNDAMENTALS OF PHARMACOLOGY , 1945 .

[53]  Thomas K. Hunt,et al.  ON THE TREATMENT OF , 1846 .

[54]  R. Kizek,et al.  Matrix metalloproteinases. , 2010, Current medicinal chemistry.

[55]  C. Overall,et al.  Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. , 2010, Biochimica et biophysica acta.

[56]  Christopher M Overall,et al.  Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. , 2006, Nature reviews. Cancer.

[57]  A. Smolka,et al.  Interleukin 1beta induces gastric epithelial cell matrix metalloproteinase secretion and activation during Helicobacter pylori infection. , 2003, Gut.